Nutra Pharma Corp (NPHC)

[stayfocused]

GM everyone, looks to be consolidating ready for the lift off as the launch approaches.

Remember, they're expecting to sell 1.5m units a month which should mean net earnings of $2.00/unit or £36m per annum, divide that by 250m fully diluted shares and add a pe of 10 and you've got a conservative pps of $1.44 and that's just the OTC revenues on a national scale. Now add the prescription based revenues and multiply it by the European and Australian figues and you can see that the potential here is awesome.

IMO those figures are very conservative and should at least double as Cobroxin takes market share going forward.